MNOV (MediciNova) Interest Received


MNOV MediciNova Inc MNOV
30 GF Score
Price $1.39
! 2 Warning Signs
View Full Analysis

What is MediciNova Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

MNOV
30GF Score
MediciNova Inc MNOV
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MediciNova Business Description

Other Exchanges 4875:Japan
Address 4275 Executive Square, Suite 300, La Jolla, CA, USA, 92037
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
30GF Score

Get the complete analysis for MNOV

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.39
Price